EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multilevel HierCC typing scheme for global genomic epidemiology and antimicrobial resistance surveillance of Campylobacter jejuni

Ruochen Wu iD, Sandeep Kaur iD, Michael Payne iD, Li Zhang iD, Ruiting Lan iD

Antimicrobial Agents and Chemotherapy · 2026

DOI: 10.1128/aac.00310-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Ruochen Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia. Hauptthemen laut MEDLINE: Campylobacter jejuni, Anti-Bacterial Agents, Campylobacter Infections, Drug Resistance, Bacterial. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, University of New South Wales.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Campylobacter jejuni is the most common bacterial cause of human gastroenteritis around the world. A stable, scalable, and standardized typing scheme is essential for epidemiological and antimicrobial resistance (AMR) surveillance for prevention and control of C. jejuni infections. We curated, assembled, and quality-filtered a C. jejuni global whole-genome sequencing (WGS) data set of 63,012 publicly available Illumina short-read genomes. A C. jejuni global cgMLST scheme with 1,161 core loci was developed using a representative subset of 2,587 genomes. We compared the HierCC clustering of the cgMLST profiles at every allelic distance, and identified nine epidemiologically meaningful levels to form a novel multilevel HierCC typing (MHT) scheme. AMR prediction was performed for the global data set using AbritAMR and integrated with the MHT scheme. The multilevel design provides flexible typing resolution for both short- and long-term epidemiological investigations and allows natural and genetically discrete clusters to be described consistently at both global and local scales. We showcased the utility of the scheme with the identification of country- and continent-specific clusters at HC264 to HC19 levels and differentiation of farm-animal-specific (specialist) from human infection (generalist) clusters at HC264 to HC55 levels. In the U.S. dataset from 2016 to 2022, a total of 276 antibiotic-resistant clusters were identified, with 22 resistant clusters increasing in frequency in recent years. An increased prevalence of C. jejuni carrying 50S_L22 mutations in the USA was observed from 2016 to 2022, suggesting continuing selection pressure from macrolide use in farm animals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Campylobacter jejuniAnti-Bacterial AgentsCampylobacter InfectionsDrug Resistance, BacterialHumansWhole Genome SequencingGenome, BacterialAnimalsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Campylobacter jejuniantimicrobial resistancegenomic surveillancemultilevel HierCC typing

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.

ORCID-Profile: Ruochen Wu, Sandeep Kaur, Michael Payne, Li Zhang, Ruiting Lan

Förderung

  • National Health and Medical Research Council
  • University of New South Wales

Zitieren

APA

Wu, R., Kaur, S., Payne, M., Zhang, L., & Lan, R. (2026). Multilevel HierCC typing scheme for global genomic epidemiology and antimicrobial resistance surveillance of Campylobacter jejuni. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00310-26

Vancouver

Wu R, Kaur S, Payne M, Zhang L, Lan R. Multilevel HierCC typing scheme for global genomic epidemiology and antimicrobial resistance surveillance of Campylobacter jejuni. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.00310-26

BibTeX
@article{Wu2026,
  author = {Wu, Ruochen and Kaur, Sandeep and Payne, Michael and Zhang, Li and Lan, Ruiting},
  title = {Multilevel HierCC typing scheme for global genomic epidemiology and antimicrobial resistance surveillance of Campylobacter jejuni},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.00310-26}
}
Kostenlos starten →